Drugs Made In America Acquisition Corp. (DMAAR)
↓ Download CSV| Metric (FY) | 2025 | 2024 |
|---|---|---|
| Operating Income | -$2.82M | — |
| Net Income | $5.94M | — |
| Total Assets | $239.92M | $550.8K |
| Total Liabilities | $7.28M | $795.7K |
| Shareholders' Equity | -$7.26M | -$244.8K |
| Operating Cash Flow | -$539.2K | — |
| Shares Outstanding | 10.72M | 9.86M |